GAME Year to date has changed -0.70% percent. -1.05% in the

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
GAME Year to date has changed -0.70% percent. -1.05% in the last 30 days. $GAME

Shanda Games Limited Full breakdown
Last price 5.64
Weighted Alpha -17.14
YTD Percent -0.70%
1-Month Percent -1.05%
3-Month Percent -14.02%
1-Year Percent -15.32%

More about Shanda Games Limited stock
http://investorshangout.com/Shanda-Games-Limited-GAME-54204/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 288

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 244

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 164

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 387

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 185

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 201

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 302

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 224

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 185

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 322

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Projected Growth of Collagen Market to Hit $22.7 Billion

Updated Category News Views 73

The Collagen Market: A Growing Landscape The collagen market is undergoing an impressive transformation, with estimates suggesting it will reach around USD 22.7 billion in the coming years. As of 2023, the market is valued at approximately USD 9.8 billion and is set for a compound annual growth rate (CAGR) of 9.8% from 2024 to 2032. This growth is propelled by increasing...

Continue Reading
Enfusion Shares Third Quarter Performance Insights for 2024

Updated Category News Views 41

Enfusion Reports Impressive Third Quarter Financial Results Enfusion, Inc. (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions tailored for investment managers, has released its financial results for the third quarter of 2024. These results were included in a detailed Shareholder Letter accessible through their Investor Relations platform. Quarterly...

Continue Reading
EUBG's Q2 Results: Revenue Fall Amid New Ventures

Updated Category News Views 9

Uneven Terrain for Entrepreneur Universe Bright Group Try strapping in for a roller coaster ride with this latest release from Entrepreneur Universe Bright Group. Revenue took a dive, yet they clapped for themselves for keeping some coin in the bank. For the second quarter of 2026, we saw revenue drop like a lead balloon—to $746,113 from last year’s $1,143,106. Now if...

Continue Reading
Koii Network ($KOII) Launches Trading on Key Exchanges

Updated Category News Views 457

Koii Network ($KOII) Begins Trading on Prominent Exchanges Following a highly successful mainnet launch along with multiple oversubscribed token sales, Koii Network ($KOII) has officially started trading on Gate.io and MEXC. This initiative marks a significant milestone, showcasing the power of the World's Biggest Supercomputer that emphasizes decentralized computing....

Continue Reading
Analysts Predict Strong Q2 for Bullish; Insights on Performance

Updated Category News Views 315

Anticipated Earnings Call for Bullish Bullish (BLSH) is poised to share its earnings results for the upcoming quarter following the market close. Investors and analysts alike are keenly observing this release as it promises valuable insights into the company's financial health. Expected Financial Performance Analysts predict that the company will report a quarterly loss...

Continue Reading